4.4 Review

C9ORF72 protein function and immune dysregulation in amyotrophic lateral sclerosis

期刊

NEUROSCIENCE LETTERS
卷 713, 期 -, 页码 -

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2019.134523

关键词

Amyotrophic lateral sclerosis; Neurodegeneration; Immunology; C9ORF72; Proteostasis

资金

  1. Amgen
  2. New York Stem Cell Foundation
  3. Tau Consortium
  4. NINDS [RO1 1R01NS097850-01]
  5. NINDS SBIR [1R44NS097094-01A1]
  6. Harrington Discovery Institute
  7. Alzheimer's Drug Discovery Foundation
  8. Association for Frontotemporal Dementia
  9. John Douglas French Alzheimer's Foundation

向作者/读者索取更多资源

Amyotrophic lateral sclerosis (ALS) is a rapidly progressing disease that affects upper and lower motor neurons eventually leading to paralysis and death by respiratory dysfunction. The most common genetic variant among ALS patients is a hexanucleotide repeat expansion within the first intron of the gene C9ORF72. This expansion elicits a complex cascade of events as a result of both gain- and loss-of-function mechanisms that contribute to neurodegeneration. Increasing evidence suggests that this repeat expansion in C9ORF72 also influences the immune homeostasis. In this review, we consolidate the current understanding of C9ORF72-mediated pathogenesis in both the central nervous system and peripheral immune system and propose mechanisms by which the immune system contributes to ALS.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据